If Biovail action fails, Melnyk vows to start new drug firm TORONTO - The fog of confusion around Biovail Corp.deepened Wednesday as founder and former chairman Eugene Melnyk, now the head of a dissident shareholder group, announced he will launch a new drug company but only if he fails in his bid...
Court likely next stop for Biovail battle Shareholders back board; Melnyk pulls votes in protest More On This Story Story Tools -+ Change font size Share This Story Story tools presented by Peter Jones/ReutersBiovail Corp.expects its founder Eugene Melnyk to take his battle for...
Melnyk keeps on fighting Mark Blinch, ReutersBATTLE FOR BIOVAIL HEADED FOR COURT: Biovail company founder and majority shareholder Eugene Melnyk yesterday announced plans for a new drug company after his attempt to replace Biovail's board of directors ...The fog...
Learn about the Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and Leading Drug Delivery Companies and Technologies Business Intelligence for the Pharmaceutical Industry Business Insights' portfolio of healthcare management reports is designed to help you make well informed and timely business decisions.
Learn about the Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and Leading Drug Delivery Companies and Technologies Competitive landscape, company profiles and technological developments Business Intelligence for the Pharmaceutical Industry Business Insights' portfolio of healthcare management reports is...
Learn about the Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and Leading Drug Delivery Companies and Technologies Competitive landscape, company profiles and technological developments Business Intelligence for the Pharmaceutical Industry Business Insights' portfolio of healthcare management reports is...
Learn about the Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments http://www.reportlinker.com/p090379/Leading-Drug-Delivery-Companies-and-Technologies-Competitive-landscape-company...
Biovail declines after generic threats, development questions lead to downgrade NEW YORK (AP) - Shares of drug developer Biovail Corp.sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.
Biovail is shifting its focus...
Biovail stock falls after analyst cuts rating NEW YORKShares of drug developer Biovail Corp.sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.Biovail is shifting its focus to central...
Biovail stock falls after analyst cuts rating NEW YORK - Shares of drug developer Biovail Corp.sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.
Biovail is shifting its focus to...
Biovail declines after generic threats and development questions lead to analyst downgrade - 3:08 p.m.NEW YORK (AP) - Shares of drug developer Biovail Corp.
sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.
Biovail is...
Biovail stock falls after analyst cuts rating Shares of drug developer Biovail Corp.sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.
Biovail is shifting its focus to central...
Biovail stock falls after analyst cuts rating NEW YORK (AP) - Shares of drug developer Biovail Corp.sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.
Biovail is shifting its focus...
Biovail stock falls after analyst cuts rating Shares of drug developer Biovail Corp.sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.
Biovail (nyse: BVF - news - people ) is...
Biovail stock falls after analyst cuts rating NEW YORK (AP) -- Shares of drug developer Biovail Corp.sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts will be costly.
Biovail is shifting its focus...
Challenger wants debate with Biovail CEO TORONTO The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug companys current chief executive to a debate in the latest move in a proxy fight between Biovails current management and Melnyk.
In a...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.
In...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate - 7:05 pm TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.
In...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate TORONTO, The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.
In a...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate AMTORONTO, The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.
In a...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.
In...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.
In...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.
In...
Melnyk's proposed CEO challenges Biovail CEO Bill Wells to debate TORONTO - The man proposed by Eugene Melnyk to head Biovail Corp.(TSX:BVF) challenged Monday the drug company's current chief executive to a debate in the latest move in a proxy fight between Biovail's current management and Melnyk.
In...
